Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Age-Stratified Busulfan-Based Conditioning Regimens in Adult MDS Patients Receiving Haploidentical HSCT
NCT07677306Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan in myelodysplastic syndrome (MDS), sponsored by Peking University People's Hospital. Started Jul 2026; status: recruiting.
02
Drugs
busulfan
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT07677306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07677306.